Epstein Secrets

62 United States v. Jimenez, 824 F. Supp. 351 (S.D.N.Y. 1993) 240, 268 United States v. Johns, 15 F.3d 740 (8th Cir. 1994) 37 United States v. Johnson, 21 F. Supp. 2d 329 (S.D.N.Y. 1998) 294 United States v. Jones, 482 F.3d 60 (2d Cir. 2006) 259 United States v. Joseph berg, 459 F.3d 350 (2d

ges, 346 U.S. at 216. There is no corresponding indication that Congress intended the "essential ingredients" test to apply to Section 3283. As the Third Circuit has explained in rejecting an identical argument: While Bridges did adopt an "essential ingredient" test, the limitations-extending statute at issu

2014) 140 Int'l Equity !nvs., Inc. v. Opportunity Equity Partners Ltd., No. 05 Civ. 2745 (JGK) (RLE), 2010 WL 779314 (S.D.N.Y. Mar. 2, 2010) 111 Johnson v. United States, 520 U.S. 461 (1997) 200 Kungys v. United States, 485 U.S. 759 (1988) 222 Landgraf v. USI Film Products, 511 U.S. 244 (1994)

ges, 346 U.S. at 216. There is no corresponding indication that Congress intended the "essential ingredients" test to apply to Section 3283. As the Third Circuit has explained in rejecting an identical argument: While Bridges did adopt an "essential ingredient" test, the limitations-extending statute at issu

2014) 140 Int'l Equity !nvs., Inc. v. Opportunity Equity Partners Ltd., No. 05 Civ. 2745 (JGK) (RLE), 2010 WL 779314 (S.D.N.Y. Mar. 2, 2010) 111 Johnson v. United States, 520 U.S. 461 (1997) 200 Kungys v. United States, 485 U.S. 759 (1988) 222 Landgraf v. USI Film Products, 511 U.S. 244 (1994)

ges, 346 U.S. at 216. There is no corresponding indication that Congress intended the "essential ingredients" test to apply to Section 3283. As the Third Circuit has explained in rejecting an identical argument: While Bridges did adopt an "essential ingredient" test, the limitations-extending statute at issu

cisions as well. (II Due process requires the govern- ment to adhere to the terms of any plea bargain or immunity agreement it makes. Ste Mabry v. Johnson, 467 U.S. 504, 104 S.Ct. 2643, 81 L.Ed.2t1 437 (1984) (plea agreement); Santobetto v. New York, 404 (the date of the immunity agreement). or any

nding that it was not frivol- ous. It is a `close' question or one that very well could be decided the othe " Gi- ancola, 754 F.2d at 901. In the Third Circuit said that a "substan r ues- tion under § 3143(6)(2) is one white is either novel, which has not been decided by controllaedent, or which is fairl

014) 140 Intl Equity !nvs., Inc. v. Opportunity Equity Partners Ltd., No. 05 Civ. 2745 (JGK) (RLE), 2010 WL 779314 (S.D.N.Y. Mar. 2, 2010) 111 Johnson v. United States, 520 U.S. 461 (1997) 200 Kungys v. United States, 485 U.S. 759 (1988) 222 Landgraf v. USI Film Products, 511 U.S. 244 (1994)

ges, 346 U.S. at 216. There is no corresponding indication that Congress intended the "essential ingredients" test to apply to Section 3283. As the Third Circuit has explained in rejecting an identical argument: While Bridges did adopt an "essential ingredient" test, the limitations-extending statute at issu